e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Clinical aspects in pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study
M. Masjedi, N. Hashemi Sadraei, A. Fakharian, S. M. Marashian (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Session:
Clinical aspects in pulmonary fibrosis
Session type:
Thematic Poster Session
Number:
4202
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Masjedi, N. Hashemi Sadraei, A. Fakharian, S. M. Marashian (Tehran, Islamic Republic Of Iran). Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study. Eur Respir J 2010; 36: Suppl. 54, 4202
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016
Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019
Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study
Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021
Year: 2022
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study.
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Survival in idiopathic pulmonary fibrosis: results of the IFIGENIA follow up study
Source: Eur Respir J 2004; 24: Suppl. 48, 254s
Year: 2004
Longitudinal observation of idiopathic pulmonary fibrosis (IPF) patients cohort from one center in Poland.
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Familial cases of idiopathic pulmonary fibrosis: Clinical observation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study
Source: Eur Respir J, 54 (1) 1900103; 10.1183/13993003.00103-2019
Year: 2019
Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Clinical features in patients diagnosed of pulmonary hypertension: a retrospective study of 15 cases
Source: Eur Respir J 2005; 26: Suppl. 49, 520s
Year: 2005
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study
Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018
Year: 2019
Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Idiopathic pulmonary fibrosis in children (PIPF): a case series from Iran
Source: Eur Respir J 2006; 28: Suppl. 50, 305s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept